Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Franken, Margreet
Nilsson, Fredrik
Sandmann, Frank
de Boer, Anthonius
and
Koopmanschap, Marc
2013.
Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making.
PharmacoEconomics,
Vol. 31,
Issue. 9,
p.
781.
Drummond, Michael
de Pouvourville, Gerard
Jones, Elizabeth
Haig, Jennifer
Saba, Grece
and
Cawston, Hélène
2014.
A Comparative Analysis of Two Contrasting European Approaches for Rewarding the Value Added by Drugs for Cancer: England Versus France.
PharmacoEconomics,
Vol. 32,
Issue. 5,
p.
509.
Fischer, Katharina E.
and
Stargardt, Tom
2014.
Early Benefit Assessment of Pharmaceuticals in Germany.
Medical Decision Making,
Vol. 34,
Issue. 8,
p.
1030.
Grepstad, Mari
and
Kanavos, Panos
2015.
A comparative analysis of coverage decisions for outpatient pharmaceuticals: Evidence from Denmark, Norway and Sweden.
Health Policy,
Vol. 119,
Issue. 2,
p.
203.
Widrig, Daniel
2015.
Health Technology Assessment.
Vol. 44,
Issue. ,
p.
347.
Fischer, Katharina Elisabeth
Heisser, Thomas
and
Stargardt, Tom
2016.
Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia.
Health Policy,
Vol. 120,
Issue. 10,
p.
1115.
Zeichner, Simon B.
Kohn, Christine G.
and
Goldstein, Daniel A.
2016.
Economics of ramucirumab for metastatic colorectal cancer.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 16,
Issue. 6,
p.
733.
Allen, Nicola
Liberti, Lawrence
Walker, Stuart R.
and
Salek, Sam
2017.
A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?.
Frontiers in Pharmacology,
Vol. 8,
Issue. ,
Kawalec, Paweł
Malinowski, Krzysztof Piotr
and
Trąbka, Wojciech
2018.
Trends and determinants in reimbursement decision-making in Poland in the years 2013–2015.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 18,
Issue. 2,
p.
197.
Abbas, Nasir
Hasan, Syed Shahzad
Curley, Louise
and
Babar, Zaheer- Ud-Din
2020.
Access to medicines - a systematic review of the literature.
Research in Social and Administrative Pharmacy,
Vol. 16,
Issue. 9,
p.
1166.
Mela, Aneta
Rdzanek, Elżbieta
Jaroszyński, Janusz
Furtak-Niczyporuk, Marzena
Jabłoński, Mirosław
and
Niewada, Maciej
2023.
Reimbursement decision-making system in Poland systematically compared to other countries.
Frontiers in Pharmacology,
Vol. 14,
Issue. ,
Mela, Aneta
Tysarowski, Andrzej
Rdzanek, Elżbieta
Blicharski, Tomasz
Jaroszyński, Janusz
Furtak-Niczyporuk, Marzena
Jahnz-Różyk, Karina
and
Niewada, Maciej
2025.
Time from approval to reimbursement recommendations in healthcare systems with centralized HTA processes. Focus on the Polish HTA agency.
Expert Review of Pharmacoeconomics & Outcomes Research,
Vol. 25,
Issue. 2,
p.
265.